Responsibilities unasked for and the role of the USPSTF

A commentary in this week’s issue of the New England Journal of Medicine provides some valuable, historical insight into how it was that the U.S. Preventive Services Task Force (USPSTF) ended up with responsibilities that many of its members never wanted. … READ MORE …

Suggestions of bias in decisions about who got biopsies in the SELECT trial

A re-analysis of data from men participating in the placebo arms of the Prostate Cancer Prevention Trial (PCPT) and the Selenium and Vitamin E Cancer Prevention Trial (SELECT) has suggested a problem with bias in decisions about who gets biopsies during certain types of clinical trial. … READ MORE …

A potential new model for prostate cancer screening?

A highly influential group of senior urologists have come together to propose a new model as a methodology for screening men for risk of prostate cancer. … READ MORE …

Of politics, prostate cancer, screening, and editorial opinions

We don’t often refer to articles in what are primarily political publications like The Hill, but an OpEd in that journal this week did catch our attention, and not in a particularly good way either. … READ MORE …

PSA testing in the “real world” … from 2010 to 2015

A newly published article in the journal Cancer suggests that, in fact, the USPSTF guidance on use of the PSA test for risk of prostate cancer has had little impact in the “real world” between 2010 and 2015 (at least at one large tertiary care institution in Texas). … READ MORE …

The impact of the USPSTF recommendation against screening: another take

A research letter from the epidemiologists and statisticians at the American Cancer Society has just been published in JAMA Oncology. The full text of the research letter is available on line. … READ MORE …

The politics of PSA testing

We continue to see a steady stream of articles in the cancer literature that appears to be designed to influence the thinking of the U.S. Preventive Services Task Force (USPSTF) as they reconsider the value of PSA testing in assessment of risk for prostate cancer. … READ MORE …